The role of T-regulatory cells in the pathogenesis of immunological disturbances accompanying obesity and atherosclerosis;Rola limfocytów T-regulatorowych w patogenezie zaburzeń immunologicznych towarzysza̧cych otyłości i miażdżycy

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 64, Issue , 2010, Pages 156-160

  Łuczyński, Włodzimierz ^a   Bossowski, Artur ^a   Głowińska Olszewska, Barbara ^a   Kos, Justyna ^b   Baran, Marcin ^a   Stasiak Barmuta, Anna ^c  

^a Klinika Pediatrii   (Poland)

^b Stomatologia w Białymstoku ^*  (Poland)

^c Uniwersytetu Medycznego w Bia ymstoku   (Poland)

Author keywords

Atherosclerosis; Immunotherapy; Metabolic syndrome; Obesity; T regulatory cells

Indexed keywords

ANIMAL; ATHEROSCLEROSIS; HUMAN; IMMUNOLOGY; METABOLIC SYNDROME X; OBESITY; REGULATORY T LYMPHOCYTE; REVIEW;

ANIMALS; ATHEROSCLEROSIS; HUMANS; METABOLIC SYNDROME X; OBESITY; T-LYMPHOCYTES, REGULATORY;

EID: 77954698856     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Ait-Oufella H., Salomon B. L., Potteaux S., Robertson A. K., Gourdy P., Zoll J., Merval R., Esposito B., Cohen J. L., Fisson S., Flavell R. A., Hansson G. K., Klatzmann D., Tedgui A., Mallat Z.: Natural regulatory T cells control the development of atherosclerosis in mice. Nat. Med., 2006;12:178-180 (Pubitemid 43214743)
2. Bluestone J. A., Tang Q., Sedwick C. E.: T regulatory cells in autoimmune diabetes: past challenges, future prospects. J. Clin. Immunol., 2008;28:677-684
3. de Boer O. J., van der Meer J. J., Teeling P., van der Loos C. M., van der Wal A. C.: Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions. PLoS One, 2007;2:e779
4. Feuerer M., Herrero L., Cipolletta D., Naaz A., Wong J., Nayer A., Lee J., Goldfine A. B., Benoist C., Shoelson S., Mathis D.: Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nature Medicine, 2009;15:930-939
5. Gotsman I., Grabie N., Gupta R., Dacosta R., MacConmara M., Lederer J., Sukhova G., Witztum J. L., Sharpe A. H., Lichtman A. H.: Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule. Circulation, 2006;114:2047-2055 (Pubitemid 44706881)
6. Hansson G. K.: Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med., 2005;352:1685-1695
7. Hansson G. K., Holm J., Jonasson L.: Detection of activated T lymphocytes in the human atherosclerotic plaque. Am. J. Pathol., 1989;135:169-175 (Pubitemid 19229001)
8. Heller E. A., Liu E., Tager A. M., Yuan Q., Lin A. Y., Ahluwalia N., Jones K., Koehn S. L., Lok V. M., Aikawa E., Moore K. J., Luster A. D., Gerszten R. E.: Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells. Circulation, 2006;113:2301-2312 (Pubitemid 43947976)
9. Jawień J.: Nowe, immunologiczne spojrzenie na patogenezȩ miażdżycy. Pol. Arch. Med. Wewn., 2008;118:127-131
10. Ji Q. W., Guo M., Zheng J. S., Mao X. B., Peng Y. D., Li S. N., Liang Z. S., Dai Z. Y., Mao Y., Zeng Q. T.: Downregulation of T helper cell type 3 in patients with acute coronary syndrome. Arch. Med. Res., 2009;40:285-293
11. Kim J. A., Choi Y. S., Hong J. I., Kim S. H., Jung H. H., Kim S. M.: Association of metabolic syndrome with white blood cell subtype and red blood cells. Endocr. J., 2006;53:133-139
12. Mallat Z., Gojova A., Brun V., Esposito B., Fournier N., Cottrez F., Tedgui A., Groux H.: Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice. Circulation, 2003;108:1232-1237 (Pubitemid 37099993)
13. Mallat Z., Gojova A., Marchiol-Fournigault C., Esposito B., Kamaté C., Merval R., Fradelizi D., Tedgui A.: Inhibition of transforming growth factor-β signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ. Res., 2001;89:930-934 (Pubitemid 34627899)
14. + regulatory T cells in patients with acute coronary syndromes. Eur. Heart J., 2006;27:2530-2537 (Pubitemid 44627295)
15. Mor A., Planer D., Luboshits G., Afek A., Metzger S., Chajek-Shaul T., Keren G., George J.: Role of naturally occuring CD4+CD25+ regulatory T cells in experimental atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 2007;27:893-900 (Pubitemid 46606722)
16. Namiki M., Kawashima S., Yamashita T., Ozaki M., Sakoda T., Inoue N., Hirata K., Morishita R., Kaneda Y., Yokoyama M.: Intramuscular gene transfer of interleukin-10 cDNA reduces atherosclerosis in apolipoprotein E-knockout mice. Atherosclerosis, 2004;172:21-29 (Pubitemid 38058597)
17. + effector T cells contribute to macrophage recruitment and adipose tissue infammation in obesity. Nat. Med., 2009;15:914-920
18. Patel S., Chung S. H., White G., Bao S., Celermajer D. S.: The "atheroprotective" mediators apolipoprotein A-I and Foxp3 are over-abundant in unstable carotid plaques. Int. J. Cardiol., 2009; (w druku)
19. Robertson A. K., Hansson G. K.: T cells in atherogenesis: for better or for worse? Arterioscler. Thromb. Vasc. Biol., 2006;26:2421-2432 (Pubitemid 44607461)
20. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M.: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol., 1995;155:1151-1164
21. Sasaki N., Yamashita T., Takeda M., Shinohara M., Nakajima K., Taka H., Usui T., Hirata K.: Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice. Circulation, 2009;120:1996-2005
22. Shim W. S., Kim H. J., Kang E. S., Ahn C. W., Lim S. K., Lee H. C., Cha B. S.: The association of total and differential white blood cell count with metabolic syndrome in type 2 diabetic patients. Diabetes Res. Clin. Pract., 2006;73:284-291 (Pubitemid 44107581)
23. Steffens S., Burger F., Pelli G., Dean Y., Elson G., Kosco-Vilbois M., Chatenoud L., Mach F.: Short-term treatment with anti-CD3 antibody reduces the development and progression of atherosclerosis in mice. Circulation, 2006;114:1977-1984 (Pubitemid 44665393)
24. Svec P., Vásárhelyi B., Pászthy B., Körner A., Kovács L., Tulassay T., Treszl A.: Do regulatory T cells contribute to Th1 skewness in obesity? Exp. Clin. Endocrinol. Diabetes, 2007;115:439-443 (Pubitemid 47234644)
25. Taleb S., Herbin O., Ait-Oufella H., Verreth W., Gourdy P., Barateau V., Merval R., Esposito B., Clément K., Holvoet P., Tedgui A., Mallat Z.: Defective leptin/leptin receptor signaling improves regulatory T cell immune response and protects mice from atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 2007;27:2691-2698 (Pubitemid 350158924)
26. Tanigawa T., Iso H., Yamagishi K., Muraki I., Kawamura N., Nakata A., Sakurai S., Ohira T., Shimamoto T.: Association of lymphocyte sub-populations with clustered features of metabolic syndrome in middle-aged Japanese men. Atherosclerosis, 2004;173:295-300 (Pubitemid 38469799)
27. Tian Y., Yuan Z., Liu Y., Liu W., Zhang W., Xue J., Shen Y., Liang X., Chen T., Kishimoto C.: Pioglitazone modulates the balance of effector and regulatory T cells in apolipoprotein E deficient mice. Nutr. Metab. Cardiovasc. Dis., 2009; (w druku)
28. van Puijvelde G. H., Hauer A. D., de Vos P., van den Heuvel R., van Herwijnen M. J., van der Zee R., van Eden W., van Berkel T. J., Kuiper J.: Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis. Circulation, 2006;114:1968-1976 (Pubitemid 44665392)
29. van Puijvelde G. H., van Es T., van Wanrooij E. J., Habets K. L., de Vos P., van der Zee R., van Eden W., van Berkel T. J., Kuiper J.: Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 2007;27:2677-2683 (Pubitemid 350158922)
30. Vignali D. A., Collison L. W., Workman C. J.: How regulatory T cells work. Nat. Rev. Immunol., 2008;8:523-532
31. Winer S., Chan Y., Paltser G., Truong D., Tsui H., Bahrami J., Dorfman R., Wang Y., Zielenski J., Mastronardi F., Maezawa Y., Drucker D. J., Engleman E., Winer D., Dosch H. M.: Normalization of obesity-associated insulin resistance through immunotherapy. Nat. Med., 2009;15:921-929
32. Xie J. J., Wang J., Tang T. T., Chen J., Gao X. L., Yuan J., Zhou Z. H., Liao M. Y., Yao R., Yu X., Wang D., Cheng Y., Liao Y. H., Cheng X.: The Th17/Treg functional imbalance during atherogenesis in ApoE (-/-) mice. Cytokine, 2010;49:185-193
33. Yang K., Li D., Luo M., Hu Y.: Generation of HSP60-specific regulatory T cell and effect on atherosclerosis. Cell. Immunol., 2006;243:90-95 (Pubitemid 46437321)